These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 3165056

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of pneumonia with imipenem/cilastatin.
    Beasley CR, Humble MW, O'Donnell TV.
    N Z Med J; 1985 Jun 26; 98(781):494-7. PubMed ID: 3859775
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intramuscular imipenem/cilastatin for treatment of mild and moderately severe bacterial infections.
    Keller CA, Villavicencio J, Ramirez C.
    Scand J Infect Dis Suppl; 1987 Jun 26; 52():26-31. PubMed ID: 3483287
    [Abstract] [Full Text] [Related]

  • 6. Randomized, comparative trial of imipenem/cilastatin and moxalactam in the treatment of serious obstetric and gynecologic infections.
    Berkeley AS, Freedman KS, Hirsch JC, Ledger WJ.
    Surg Gynecol Obstet; 1986 Mar 26; 162(3):204-8. PubMed ID: 3513346
    [Abstract] [Full Text] [Related]

  • 7. Imipenem/cilastatin therapy of serious infections: a U.S. multicenter noncomparative trial.
    Calandra GB, Hesney M, Brown KR.
    Clin Ther; 1985 Mar 26; 7(2):225-38. PubMed ID: 3886144
    [Abstract] [Full Text] [Related]

  • 8. Imipenem/cilastatin therapy for serious infections in neonates and infants.
    Nalin DR, Jacobsen CA.
    Scand J Infect Dis Suppl; 1987 Mar 26; 52():46-55. PubMed ID: 3331042
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Early clinical experience with imipenem-cilistatin.
    Ellis-Pegler RB, Downey D, Bremner DA.
    N Z Med J; 1985 Mar 27; 98(775):188-91. PubMed ID: 3856762
    [Abstract] [Full Text] [Related]

  • 12. Imipenem/cilastatin for pediatric infections in hospitalized patients.
    Nalin DR, Hart CB, Shih WJ, Aziz MA.
    Scand J Infect Dis Suppl; 1987 Mar 27; 52():56-64. PubMed ID: 3331043
    [Abstract] [Full Text] [Related]

  • 13. [Clinical evaluation of imipenem/cilastatin sodium in gynecological infection].
    Iwaki M, Sato H, Makinoda S, Demise M, Tabata M, Yamaguchi T, Takaoka H, Shinkai N, Okubo H, Sato H.
    Jpn J Antibiot; 1986 Jun 27; 39(6):1509-13. PubMed ID: 3463791
    [Abstract] [Full Text] [Related]

  • 14. Imipenem/cilastatin versus aminoglycoside plus amoxicillin plus clindamycin in the treatment of serious postoperative infections.
    Christen D, Buchmann P, Geroulanos S.
    Scand J Infect Dis Suppl; 1987 Jun 27; 52():11-4. PubMed ID: 3331039
    [Abstract] [Full Text] [Related]

  • 15. Imipenem/cilastatin: the first carbapenem antibiotic.
    Lyon JA.
    Drug Intell Clin Pharm; 1985 Dec 27; 19(12):895-9. PubMed ID: 3910385
    [Abstract] [Full Text] [Related]

  • 16. Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia.
    Bartoloni A, Strohmeyer M, Corti G, Buonomini MI, Franchino L, Romanelli G, Moretti AM, De Vizzi GB, Petraglia A, Mancini P, Atzeni R, Fogliani V, Giura R, Paradisi F.
    Drugs Exp Clin Res; 1999 Dec 27; 25(6):243-52. PubMed ID: 10713862
    [Abstract] [Full Text] [Related]

  • 17. Imipenem/cilastatin as empirical treatment of severe infections in compromised patients.
    Biglino A, Bonasso M, Gioannini P.
    J Chemother; 1991 Jan 27; 3 Suppl 1():208-12. PubMed ID: 12041767
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of imipenem/cilastatin against nosocomial infections and multiresistant pathogens.
    Giamarellou H, Sfikakis P, Voutsinas D, Galanakis N, Daikos GK.
    J Antimicrob Chemother; 1986 Dec 27; 18 Suppl E():175-9. PubMed ID: 3469191
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical efficacy, safety and tolerability of intramuscular imipenem/cilastatin in the treatment of mild to moderate infections.
    Garau J, Casagrán A, Sánchez C, Matas E.
    J Antimicrob Chemother; 1986 Dec 27; 18 Suppl E():181-3. PubMed ID: 3469192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.